Utah Medical Products, Inc.

UTMD · NasdaqGS · Stock · Healthcare
$75.04
+0.33% today
Delayed price,

What Utah Medical Products does

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Key facts

Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$238.2M
P/E (ttm)
22.9
Forward P/E
—
Dividend yield
1.66%
Beta
0.39
Profit margin
29.0%
Employees
140
Headquarters
Midvale, UT, United States
Exchange
NasdaqGS

Performance

1 Month
+1.5%
3 Months
+7.5%
6 Months
+6.2%
1 Year
+26.2%
5 Years
-32.7%
$53.6652-week range$76.89
Biggest setback — last 12 months
-10.3%
13 Apr 2026 → 11 May 2026
Fell from $70.65 to $63.34 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+36.0%
17 Nov 2025 → 15 Oct 2026
Ran from $55.16 to $75.04 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▲ Trend: Uptrend
Price is above its 20-, 50- and 200-day averages, each stacked above the next — a classic technical uptrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$69.20 (-7.8%)$75.04$81.38 (+8.4%)
3 Months$65.21 (-13.1%)$75.04$86.35 (+15.1%)
6 Months$61.53 (-18.0%)$75.04$91.52 (+22.0%)
12 Months$56.67 (-24.5%)$75.04$99.36 (+32.4%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 28.1%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 150 shares at $73.07 — RICHINS PAUL O, Director · 2026-07-01
Sold 50 shares at $66.27 — Koopman Brian, Principal Financial Officer · 2026-05-29
Acquired 500 shares — Koopman Brian, Principal Financial Officer · 2025-11-25
Sold 50 shares at $62.75 — Koopman Brian, Principal Financial Officer · 2025-09-05
Sold 100 shares at $60.34 — RICHINS PAUL O, Director · 2025-08-26
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.